IN2014CH01872A - - Google Patents
Info
- Publication number
- IN2014CH01872A IN2014CH01872A IN1872CH2014A IN2014CH01872A IN 2014CH01872 A IN2014CH01872 A IN 2014CH01872A IN 1872CH2014 A IN1872CH2014 A IN 1872CH2014A IN 2014CH01872 A IN2014CH01872 A IN 2014CH01872A
- Authority
- IN
- India
- Prior art keywords
- nanodispersion
- present disclosure
- exemplary embodiment
- aqueous dispersion
- dispersion medium
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dispersion Chemistry (AREA)
- Biochemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Colloid Chemistry (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2015246030A AU2015246030B2 (en) | 2014-04-09 | 2015-04-08 | Composition and method of producing nanoformulation of water insoluble bioactives in aqueous base |
| EP15777362.3A EP3129002A4 (fr) | 2014-04-09 | 2015-04-08 | Composition et procédé de production d'une nanoformulation de composés bioactifs insolubles dans l'eau dans un support aqueux |
| MX2016013201A MX2016013201A (es) | 2014-04-09 | 2015-04-08 | Composicion y metodo para producir una nanoformulacion de bioactivos insolubles en agua en una base acuosa. |
| US15/302,495 US11458096B2 (en) | 2014-04-09 | 2015-04-08 | Composition and method of producing nanoformulation of water insoluble bioactives in aqueous base |
| PCT/IB2015/052541 WO2015155703A2 (fr) | 2014-04-09 | 2015-04-08 | Composition et procédé de production d'une nanoformulation de composés bioactifs insolubles dans l'eau dans un support aqueux |
| IN1872CH2014 IN2014CH01872A (fr) | 2014-04-09 | 2015-04-08 | |
| EA201692044A EA038458B1 (ru) | 2014-04-09 | 2015-04-08 | Стабильная водная нанодисперсия водонерастворимых биоактивных соединений и способ ее получения |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1872CH2014 IN2014CH01872A (fr) | 2014-04-09 | 2015-04-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014CH01872A true IN2014CH01872A (fr) | 2015-05-08 |
Family
ID=54288490
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1872CH2014 IN2014CH01872A (fr) | 2014-04-09 | 2015-04-08 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11458096B2 (fr) |
| EP (1) | EP3129002A4 (fr) |
| AU (1) | AU2015246030B2 (fr) |
| EA (1) | EA038458B1 (fr) |
| IN (1) | IN2014CH01872A (fr) |
| MX (1) | MX2016013201A (fr) |
| WO (1) | WO2015155703A2 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2535666B (en) | 2014-04-30 | 2017-03-29 | Matoke Holdings Ltd | Antimicrobial compositions |
| GB201716986D0 (en) | 2017-10-16 | 2017-11-29 | Matoke Holdings Ltd | Antimicrobial compositions |
| FR3075661A1 (fr) * | 2017-12-21 | 2019-06-28 | Coatex | Emulsion submicronique |
| US11596588B2 (en) * | 2017-12-29 | 2023-03-07 | L'oreal | Compositions for altering the color of hair |
| WO2019175830A1 (fr) * | 2018-03-14 | 2019-09-19 | Azista Industries Pvt Ltd | Formulations de nano-émulsions de cholécalciférol, et procédés d'utilisation correspondants |
| WO2023118928A1 (fr) | 2021-12-21 | 2023-06-29 | Opella Healthcare Group Sas | Nanoformulation stable pour principes actifs lipophiles, forme de dosage orale et son procédé de préparation |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992018147A1 (fr) | 1991-04-19 | 1992-10-29 | Affinity Biotech, Inc. | Formulations de microemulsions a inversion de phase |
| CA2091152C (fr) | 1993-03-05 | 2005-05-03 | Kirsten Westesen | Particules lipidiques solides, particules d'agents bioactifs, et methode de preparation et d'utilisation |
| US5518738A (en) | 1995-02-09 | 1996-05-21 | Nanosystem L.L.C. | Nanoparticulate nsaid compositions |
| AU6708096A (en) * | 1995-09-18 | 1997-04-09 | Vesifact Ag | Propofol nanodispersions |
| DE19642359A1 (de) | 1996-10-14 | 1998-04-16 | Basf Ag | Stabile Emulsionen und Trockenpulver von Mischungen fettlöslicher Vitamine, deren Herstellung und Verwendung |
| US5994414A (en) | 1997-04-28 | 1999-11-30 | Avon Products, Inc. | Water-thin emulsion formed by high pressure homogenization process |
| ATE253353T1 (de) * | 2001-04-12 | 2003-11-15 | Vesifact Ag | Coenzym q10 enthaltende mikroemulsion- prekonzentrate und mikroemulsionen |
| US6780324B2 (en) * | 2002-03-18 | 2004-08-24 | Labopharm, Inc. | Preparation of sterile stabilized nanodispersions |
| CN101862292A (zh) | 2002-06-17 | 2010-10-20 | 塔罗制药美国公司 | 布洛芬混悬剂 |
| US8628690B2 (en) | 2004-02-23 | 2014-01-14 | The Texas A&M University System | Nanoemulsion compositions and methods of use thereof |
| EP1597973A1 (fr) | 2004-05-18 | 2005-11-23 | Nestec S.A. | Emulsion d'huile dans l'eau pour livraison |
| US20060051462A1 (en) * | 2004-09-03 | 2006-03-09 | Wang Jimmy X | Self emulsifying compositions for delivering lipophilic coenzyme Q10 and other dietary ingredients |
| CN101374498A (zh) | 2005-12-01 | 2009-02-25 | 麻萨诸塞州洛厄尔大学 | 肉毒杆菌纳米乳液 |
| CN101011355B (zh) * | 2006-02-01 | 2013-01-02 | 陈献 | 经维生素e琥珀酸酯稳定的医药组合物、其制备及用途 |
| EP2001439A2 (fr) | 2006-03-07 | 2008-12-17 | Novavax, Inc. | Emulsions nano-structurees des agents actifs mauvais soluble et leurs procedes de fabrication |
| EP1938801A1 (fr) | 2006-12-22 | 2008-07-02 | Biofrontera Bioscience GmbH | Nanoémulsion |
| EP2222340B1 (fr) * | 2007-11-28 | 2014-01-08 | Commonwealth Scientific and Industrial Research Organisation | Nanoémulsions |
| WO2009070642A1 (fr) * | 2007-11-28 | 2009-06-04 | Medimmune, Llc | Formulation de protéine |
| EP2201937A1 (fr) | 2008-12-23 | 2010-06-30 | Teva Pharmaceutical Industries Ltd. | Des compositions comprenant de vitamine D ou des derivatives de vitamine D |
| US9532963B2 (en) | 2009-03-09 | 2017-01-03 | Pronova Biopharma Norge As | Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof |
| ES2530049T3 (es) * | 2009-05-18 | 2015-02-26 | Sigmoid Pharma Limited | Composición que comprende gotas de aceite |
| US8778364B2 (en) * | 2009-06-19 | 2014-07-15 | Sun Pharma Advanced Research Company Ltd. | Nanodispersion of a drug and process for its preparation |
| CN102933200B (zh) * | 2009-12-18 | 2015-11-25 | 莱迪杜德制药公司 | 包含磷脂的单相凝胶组合物 |
| KR101907411B1 (ko) * | 2010-03-12 | 2018-10-12 | 베르그 엘엘씨 | 코엔자임 Q10(CoQ10)의 정맥내 제형 및 이의 사용 방법 |
| US20110229516A1 (en) * | 2010-03-18 | 2011-09-22 | The Clorox Company | Adjuvant phase inversion concentrated nanoemulsion compositions |
| SE536746C2 (sv) | 2010-05-12 | 2014-07-08 | Stora Enso Oyj | En komposition innehållande mikrofibrillerad cellulosa och en process för tillverkning av en komposition |
| US8835509B2 (en) | 2010-05-31 | 2014-09-16 | Arbro Pharmaceuticals Ltd. | Self emulsifying drug delivery system for a curcuminoid based composition |
| KR20130139896A (ko) | 2010-09-08 | 2013-12-23 | 프로노바 바이오파마 너지 에이에스 | 유리산 형태의 epa 및 dha, 계면활성제, 및 스타틴을 포함하는 조성물 |
| WO2013008083A1 (fr) | 2011-07-13 | 2013-01-17 | National Institute Of Pharmaceutical Education And Research (Niper) | Composition pharmaceutique pouvant améliorer l'efficacité anticancéreuse du tamoxifène |
| NZ596015A (en) | 2011-10-26 | 2014-04-30 | Anzamed Internat Ltd | Method and composition for the treatment of pain and/or inflammation |
| GB201204377D0 (en) | 2012-03-13 | 2012-04-25 | Givaudan Sa | Composition |
-
2015
- 2015-04-08 US US15/302,495 patent/US11458096B2/en active Active
- 2015-04-08 MX MX2016013201A patent/MX2016013201A/es active IP Right Grant
- 2015-04-08 EA EA201692044A patent/EA038458B1/ru unknown
- 2015-04-08 AU AU2015246030A patent/AU2015246030B2/en active Active
- 2015-04-08 EP EP15777362.3A patent/EP3129002A4/fr active Pending
- 2015-04-08 IN IN1872CH2014 patent/IN2014CH01872A/en unknown
- 2015-04-08 WO PCT/IB2015/052541 patent/WO2015155703A2/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US11458096B2 (en) | 2022-10-04 |
| US20180177723A1 (en) | 2018-06-28 |
| AU2015246030B2 (en) | 2020-03-12 |
| WO2015155703A3 (fr) | 2015-12-30 |
| MX2016013201A (es) | 2017-04-25 |
| EP3129002A2 (fr) | 2017-02-15 |
| EP3129002A4 (fr) | 2017-11-08 |
| WO2015155703A2 (fr) | 2015-10-15 |
| EA038458B1 (ru) | 2021-08-31 |
| EA201692044A1 (ru) | 2017-04-28 |
| AU2015246030A1 (en) | 2016-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3548450A4 (fr) | Formulations comprenant des additifs fonctionnels actifs pour l'impression 3d de polymères précéramiques et procédés d'impression 3d desdites formulations | |
| IL266018A (en) | Methods and systems for improving the stability of the pre-vapor composition of an electronic inhalation device | |
| MX2021010105A (es) | Particulas de nanoalumbre que contienen un agente de dimensionamiento. | |
| EP3215806A4 (fr) | Suivi, télémétrie et/ou imagerie 3d à l'aide de l'ingénierie à fonction d'étalement de point et d'éclairage actif | |
| EP3131937A4 (fr) | Dispersion aqueuse et composition de revêtement comprenant celle-ci | |
| MX2019006158A (es) | Sistemas polimerícos para dispersión de partículas. | |
| HK1252512A1 (zh) | 向眼部遞送藥劑的方法 | |
| EP3039049A4 (fr) | Polymère auto-réticulable et dispersion aqueuse comprenant des particules dudit polymère | |
| EP3608415A4 (fr) | Particules de polyhydroxyalcanoate et dispersion aqueuse de celles-ci | |
| WO2015155703A3 (fr) | Composition et procédé de production d'une nanoformulation de composés bioactifs insolubles dans l'eau dans un support aqueux | |
| PL3229976T3 (pl) | Wodna dyspersja poliuretanopolimocznikowa i wodny lakier bazowy zawierający tę dyspersję | |
| JP2015110565A5 (fr) | ||
| HK1225613A1 (zh) | 赖谷胰岛素的稳定制剂 | |
| EP3108869A4 (fr) | Dispersion aqueuse de particules de poudre inorganique soumises à un traitement de surface organique hydrophobe, et produit cosmétique la contenant | |
| WO2014160185A3 (fr) | Modulateurs de l'aldéhyde déshydrogénase-2 mitochondriale et leurs procédés d'utilisation | |
| PL3230336T3 (pl) | Wodna dyspersja poliuretanopolimocznikowa i wodny lakier bazowy zawierający dyspersję | |
| PL3448902T3 (pl) | Wodna dyspersja i jej zastosowania | |
| EP3510091A4 (fr) | Formulation d'agent de modification de surface | |
| WO2014172608A3 (fr) | Dérivés de parthénolide et modulation par ceux-ci de processus commandés par translation régulée | |
| PH12016500855A1 (en) | Pharmaceutical preparation and method of its production and use | |
| EP3083282A4 (fr) | Pneumatiques et autres objets ayant un traitement de surface aérodynamique/hydrodynamique | |
| EP3287786A3 (fr) | Composes et methodes pour la surveillance active du cancer de la prostate | |
| Biswas | Gevrey regularity for the supercritical quasi-geostrophic equation | |
| GB2580276B (en) | Improved performance of dispersed location-based deduplication | |
| PH12017500700A1 (en) | Stable aqueous dispersions of zinc phosphates |